Abstract:All foreign bodies inserted in the circulatory system are thrombogenic and require temporary or lifelong antithrombotic therapies to prevent thrombosis. The adequate level of anticoagulation during the first few months determines the long-term durability, particularly for mechanical prostheses, and also for biological valves. Suboptimal anticoagulation is the most frequent source of mechanical valve thrombosis (MVT). The patient's clinical presentation decides how mechanical prosthetic valve obstruction is managed. If the mechanical valve thrombosis is obstructive and the patient is in a critical condition with hemodynamic instability, an immediate surgical intervention should be performed. The thrombolytic treatment is an option for left mechanical valve thrombosis in patients who have high surgical risk and no contraindications and also for right heart valve thrombosis. In non-obstructive thrombosis on the mechanical valve, patients can be asymptomatic, requiring optimization of the anticoagulant treatment. Both obstructive and non-obstructive thrombus formed on the mechanical prosthesis can result in embolic events. If the thrombus persists following anticoagulant treatment, the recommended options include thrombolytic treatment or redo surgery. Pannus can also cause obstruction of the prosthesis for which surgical treatment is the only option. While these clinical scenarios may initially appear to have straightforward solutions in terms of surgery, thrombolysis, or effective anticoagulation, real-world clinical experience often proves more complex. For instance, a patient with some usual comorbidities and non-obstructive mechanical valve thrombosis, experiencing symptoms solely by repeated systemic embolizations, might undergo all three therapeutic options due to the unpredictable nature of MVT. Therefore, treatment indications can intersect both on the time axis and depending on the patient's clinical status and the expertise of the center where he is hospitalized. Moreover, the European and American guidelines show subtle but important differences. The aim of this review was to compare these differences, comment on recent studies and evidence gaps, propose a more pragmatic algorithm combining all current recommendations, and highlight important research directions for this disease that has dominated the cardiovascular landscape for more than five decades, but for which there have been no significant recent changes in management.

Evaluation and Management of Mechanical Heart Valve Dysfunction and Thrombosis

Mechanical Prosthetic Valve Thrombosis: A Literature Review of Treatment Strategies

Mechanical valve thrombosis: Current management and differences between guidelines

Valvular heart disease: from mechanisms to management

[Management of patients with prosthetic heart valves]

Thrombosis of a mechanical aortic valve: stuck between a clot and a hard place

Prevention of Bioprosthetic Heart Valve Calcification: Strategies and Outcomes.

Surface modification of mechanical heart valves: A review

Unmet needs in valvular heart disease

Prosthetic Mitral Valve Obstruction with Left Atrial Appendage Thrombus: A Therapeutic Dilemma

Early Biological Valve Failure: Structural Valve Degeneration, Thrombosis, or Endocarditis?

Acute Heart Valve Emergencies

Complete dislodgement of a mechanical valve prosthesis: A rare but potentially life-threatening event: a case report

Utilization of Engineering Advances for Detailed Biomechanical Characterization of the Mitral-Ventricular Relationship to Optimize Repair Strategies: A Comprehensive Review

Contemporary evaluation and treatment of tricuspid regurgitation

Complications of transcatheter paravalvular leak device closure of mitral valve: An updated review of the literature and a rare case presentation

Manifestations of Prosthetic Valve Endocarditis: Lessons From Multimodality Imaging and Pathological Correlation

Pathophysiology and management of valvular disease in patients with destination left ventricular assist devices

Valvular Heart Disease: New Concepts in Pathophysiology and Therapeutic Approaches

Current Status of Catheter-based Mitral Valve Replacement

Management of acute decompensated valvular heart disease